Revance Therapeutics shares owned by DCF Advisers
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by DCF Advisers
from 13F filings
Historical chart of DCF Advisers investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by DCF Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by DCF Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $643k | 250k | 2.57 |
| 2024-03-31 | $1.3M | 263k | 4.92 |
| 2023-09-30 | $304k | 27k | 11.47 |
| 2022-06-30 | $166k | 12k | 13.83 |